Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin

Summary

Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin is a bachelor's with honors thesis^[1].

Key Facts

• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin authored James Swan^[2].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's instance of is recorded as bachelor's with honors thesis^[3].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's publisher is recorded as OUR Archive^[4].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's language of work or name is recorded as English^[5].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's country of origin is recorded as New Zealand^[6].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's publication date is recorded as +2018-00-00T00:00:00Z^[7].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's main subject is recorded as Bacteroides fragilis^[8].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's main subject is recorded as Bacteroides^[9].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's main subject is recorded as colorectal cancer^[10].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's main subject is recorded as CDH1^[11].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's main subject is recorded as non-steroidal anti-inflammatory drug^[12].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's Handle ID is recorded as 10523/8599^[13].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's title is recorded as Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin^[14].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's copyright holder is recorded as James Swan^[15].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's thesis submitted to is recorded as University of Otago^[16].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's on focus list of Wikimedia project is recorded as NZThesisProject^[17].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's copyright status is recorded as copyrighted^[18].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's thesis committee member is recorded as Mark Hampton^[19].
• Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's thesis committee member is recorded as Jackie Keenan^[20].

Body

Designation and Status

Aspirin’s role in preventing E-cadherin cleavage by the carcinogenic Bacteroides fragilis toxin's instance of is recorded as bachelor's with honors thesis^[3].